Enatumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enatumab, covering 2025-09-24 to 2025-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia [Phase 2]